Terminology Service < Semantic Lookup Platform

All terms in CHEBI

Label	Id	Description
CHEBI_49919	CHEBI_49919
arsenous acid	CHEBI_49900	[An arsenic oxoacid consisting of three hydroxy groups attached to a central arsenic atom.]
arsenic oxoacid	CHEBI_33407
arsenite(1-)	CHEBI_29242	[An arsenite ion resulting from the removal of a proton from one of the hydroxy groups of arsenous acid.]
CHEBI_49901	CHEBI_49901
terbium(3+)	CHEBI_49902
terbium molecular entity	CHEBI_37284
4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile	CHEBI_49903
CHEBI_49904	CHEBI_49904
CHEBI_49906	CHEBI_49906
tellane	CHEBI_49907
tellurium hydride	CHEBI_36649
N-acylethanolamine phosphate	CHEBI_145538	[Any carboxamide resulting from the formal condensation of a carboxylic acid with the amino group of O-phosphoethanolamine (2-aminoethyl dihydrogen phosphate).]
O-phosphoethanolamine	CHEBI_17553	[The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.]
(S)-Fasnall	CHEBI_145534	[An N-(1-benzylpyrrolidin-3-yl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine in which the chiral centre has S configuration. Both enantiomers act as fatty acid synthase inhibitors, although the (S)-enantiomer was found to be more than 4 times as active as the (R)-enantiomer.]
N-(1-benzylpyrrolidin-3-yl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine	CHEBI_145528	[A thienopyrimidine that is 5,6-dimethylthieno[2,3-d]pyrimidin-4-amine in which the amino group at position 4 has been substituted by an N-(1-benzylpyrrolidin-3-yl) group.]
(R)-Fasnall	CHEBI_145533	[An N-(1-benzylpyrrolidin-3-yl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine in which the chiral centre has R configuration. Both enantiomers act as fatty acid synthase inhibitors, although the (S)-enantiomer was found to be more than 4 times as active as the (R)-enantiomer.]
pevonedistat	CHEBI_145535	[A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine which is substituted by a (1S)-2,3-dihydro-1H-inden-1-ylnitrilo group at position 4 and by a (1S,3S,4S)-3-hydroxy-4-[(sulfamoyloxy)methyl]cyclopentyl group at position 7. It is a potent and selective NEDD8-activating enzyme inhibitor with an IC50 of 4.7 nM, and currently under clinical investigation for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes.]
sulfamidate	CHEBI_51872	[A compound where an oxygen atom and an amino group are bound to an SO2 unit.]
motixafortide	CHEBI_145536	[A heterodetic cyclic peptide that has antineoplastic activity. It is a CXC chemokine receptor 4 (CXCR4) antagonist with an IC50 value of 0.8 nM and is currently under clinical investigation for the treatment of hematological malignancies, solid tumors, and stem cell mobilization. It was granted orphan drug designation by the FDA for the treatment of pancreatic cancer in 2019.]